News for Tactile Systems Technology, Inc. (TCMD)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Total Revenue: $293 million for the full year, 6.8% growth year over year; $85.6 million in Q4, 10.2% growth year over year.Lymphedema Product Sales: $77.1 mil

Feb 18, 2025 / 10:00PM GMTOperator Please stand by. Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Tacti

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ETCompany ParticipantsSam Bentzinger - Investor...

The following slide deck was published by Tactile Systems Technology, Inc.

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 21.21% and 0.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $85.6 million, surpassing the estimated $85.41 million, marking a 10% year-over-year increase.Gross Margin: Improved to 75% from 72% in Q4 2023, refle

MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (”œTactile Medical”; the ”œCompany”) ( TCMD), a medical technology compa

Tactile Systems Technology Inc (TCMD) is set to release its Q4 2024 earnings on Feb 18, 2025. The consensus estimate for Q4 2024 revenue is $85.41 million, and

**media[533422]**

MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (”œTactile Medical”) ( TCMD), a medical technology company providing therap

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

We take our first look at Tactile Systems Technology, a medical device firm. The stock has fallen due to disappointed Q3 revenue results. Read more details here.

Shares of Tactile Systems Technology Inc (TCMD) fell 4.60% in mid-day trading on Dec 5. The stock reached an intraday low of $18.03, before recovering slightl

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Tactile Systems Technology (TCMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (”œTactile Medical”; the ”œCompany”) ( TCMD), a medical technology compa

**media[470872]**